Lumos Pharma, Inc. (LUMO) Financial Statements (2024 and earlier)

Company Profile

Business Address 4200 MARATHON BLVD.
AUSTIN, TX 78756
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:50,90058,00067,40073,66679,51186,758
Cash and cash equivalents37,86244,03856,00773,66679,51186,758
Short-term investments12,98913,94511,352   
Other undisclosed cash, cash equivalents, and short-term investments491741   
Receivables233200223168149134
Other undisclosed current assets4,8505,0534,3864,9985,3285,753
Total current assets:55,98363,25372,00978,83284,98892,645
Noncurrent Assets
Operating lease, right-of-use asset345420230   
Property, plant and equipment455253657069
Other undisclosed noncurrent assets    312395476
Total noncurrent assets:390472283377465545
TOTAL ASSETS:56,37363,72572,29279,20985,45393,190
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities6,3664,7856,4757,7796,6624,897
Employee-related liabilities2,5902,150
Accounts payable2798372757108541,799
Accrued liabilities6,0873,9486,2004,4793,6583,098
Other undisclosed current liabilities179232233(2,296)(1,830)345
Total current liabilities:6,5455,0176,7085,4834,8325,242
Noncurrent Liabilities
Long-term debt and lease obligation:    1975131
Liabilities, other than long-term debt167189    
Operating lease, liability167189 1975131
Other undisclosed noncurrent liabilities6,0006,0006,0005,9815,9255,869
Total noncurrent liabilities:6,1676,1896,0006,0196,0756,131
Total liabilities:12,71211,20612,70811,50210,90711,373
Equity
Equity, attributable to parent, including:43,66152,51959,58467,70774,54681,817
Treasury stock, value(187)(174)(170)(170)(151)(119)
Additional paid in capital187,539187,446187,164187,030186,599185,994
Accumulated other comprehensive loss(11)(5)(9)   
Accumulated deficit(143,760)(134,829)(127,483)(119,236)(111,985)(104,141)
Other undisclosed equity, attributable to parent808182838383
Total equity:43,66152,51959,58467,70774,54681,817
TOTAL LIABILITIES AND EQUITY:56,37363,72572,29279,20985,45393,190

Income Statement (P&L) ($ in thousands)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
Revenues527691512497403111
Gross profit:527691512497403111
Operating expenses(10,170)(8,726)(9,347)(8,047)(8,327)(7,842)
Operating loss:(9,643)(8,035)(8,835)(7,550)(7,924)(7,731)
Nonoperating income6836895752998011
Investment income, nonoperating559570503292745
Other nonoperating income12411972766
Loss from continuing operations before income taxes:(8,960)(7,346)(8,260)(7,251)(7,844)(7,720)
Income tax benefit 29     
Other undisclosed income from continuing operations   13   
Loss from continuing operations:(8,931)(7,346)(8,247)(7,251)(7,844)(7,720)
Loss before gain (loss) on sale of properties:(7,251)(7,844)(7,720)
Net loss available to common stockholders, diluted:(8,931)(7,346)(8,247)(7,251)(7,844)(7,720)

Comprehensive Income ($ in thousands)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
Net loss:(8,931)(7,346)(8,247)(7,251)(7,844)(7,720)
Comprehensive loss:(8,931)(7,346)(8,247)(7,251)(7,844)(7,720)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(6)4(9)   
Comprehensive loss, net of tax, attributable to parent:(8,937)(7,342)(8,256)(7,251)(7,844)(7,720)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: